Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/150945| Title: | Targeting lung tumours : phage display identification of single chain antibodies against TROP2 and TIGIT |
| Authors: | Busuttil, Kimberly (2026) |
| Keywords: | Lungs -- Cancer Lungs -- Cancer -- Immunotherapy Monoclonal antibodies -- Therapeutics use Bacteriophages Tumor antigens |
| Issue Date: | 2026 |
| Citation: | Busuttil, K. (2026). Targeting lung tumours: phage display identification of single chain antibodies against TROP2 and TIGIT (Bachelor's dissertation). |
| Abstract: | Lung cancer is the most prevalent type of cancer and continues to remain a major global cause of death. Existing treatment options such as chemotherapy, radiotherapy or surgery, frequently have low specificity, leading to toxicity and severe adverse effects. Thus, for better patient prognoses and less adverse effects, novel targeted therapies must be developed. Immunotherapies may be better alternatives as they use immune cells, which can specifically target tumour associated antigens (TAAs) and immune checkpoints. In this project, phage display biopanning was used to identify and validate single chain variable fragment (scFv) antibodies against Trophoblast Cell Surface Antigen 2 (TROP2) and T cell immunoreceptor with immunoglobulin and ITIM domain (TIGIT). However, due to consistently poor binding across all biopanning rounds, the target was subsequently changed to GlucocorticoidInduced Tumour Necrosis Factor Receptor Related Protein (GITR). A total of 75 monoclones of anti-GITR scFv displaying phages were generated and picked using a phage display library. Enzyme-linked immunosorbent assay (ELISA) was used to determine the specificity of the phage clones to the target protein GITR versus non-target protein severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) trimer. An elevated on-target signal was produced by clone 64 (p-value <0.0001). Clone 64 along with 7 non-binders were validated for their specificity, affinity and diversity using Sanger sequencing. This revealed that clone 64 was a false positive result, sharing an identical Complementarity Determining Region 3 – Variable Heavy Chain (CDR3-VH) sequence with several non-binding clones. Therefore, no functional anti-GITR scFv antibodies were identified in this study. The technical limitations encountered will guide future optimisation of library diversity, monoclonal generation and integration of high‑throughput sequencing to isolate diverse, high‑affinity scFvs against GITR. |
| Description: | B.Sc. (Hons)(Melit.) |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/150945 |
| Appears in Collections: | Dissertations - FacHSc - 2026 Dissertations - FacHScABS - 2026 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 2608HSCMLS420000016353_1.PDF Restricted Access | 3.86 MB | Adobe PDF | View/Open Request a copy |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.
